Your gift is 100% tax deductible.
Chemotherapy for Mesothelioma
Chemotherapy (chemo) is treatment with anti-cancer drugs. For mesothelioma, chemo can be given through a vein or put right into the body space where the cancer is.
When is chemotherapy used for mesothelioma?
Chemo can be used in different ways to treat mesothelioma. It is often used along with radiation therapy.
- Chemo can be used as part of the main treatment for people who aren’t getting surgery.
- If mesothelioma might be treated with surgery, chemo might be given beforehand to try to shrink the cancer and lower the risk that it will spread. This is called neoadjuvant therapy.
- Chemo can be given after surgery to try to kill any cancer cells that were left behind. This type of treatment, called adjuvant therapy, might help delay or help keep the cancer from growing back.
Chemo might not be recommended for people in poor health. Chemo can often help shrink the cancer or slow its growth, but it's very unlikely that it will make it go away completely.
How is chemotherapy given to treat mesothelioma?
There are 2 main ways chemo can be given to treat mesothelioma.
In systemic therapy, chemo is given into the blood through a vein (IV). The drug goes into the bloodstream and travels throughout the body to reach the cancer cells wherever they might be.
Doctors usually give systemic chemo in cycles, with each period of treatment followed by a rest period to allow the body time to recover. Chemo cycles generally last about 3 weeks.
Chemo drugs can also be put right into the body space where the cancer is. Chemo drugs given this way are still absorbed into the bloodstream, but the highest concentrations of the drugs go right to where the cancer cells are.
Most often this is done intraperitoneally (into the abdomen) for peritoneal mesothelioma. Rarely, it might be done intrapleurally (into the chest) for pleural mesothelioma.
This type of chemo is most often given during surgery (intraoperatively). Another option might be to give the chemo through a small catheter (tube) placed through a small cut in the abdominal or chest wall.
Types of intraperitoneal chemo
For intraperitoneal chemo, the chemo drugs are often heated before they are put into the abdomen. This is called hyperthermic intraperitoneal chemotherapy or HIPEC. Heating the chemo drugs seems to help them work better.
This treatment is often given as a single dose during surgery to remove the cancer. The chemo is typically left in place for about an hour and then removed.
Chemotherapy can also be given into the abdomen using laparoscopic surgery, either as laparoscopic HIPEC or as pressurized intraperitoneal aerosol chemotherapy (PIPAC).
Chemotherapy drugs used for mesothelioma
Different chemo drugs can be used to treat mesothelioma, including:
- Pemetrexed
- Cisplatin
- Carboplatin
- Gemcitabine
- Vinorelbine
Chemo is often given as a combination of 2 drugs. But single drugs can be used in people who might not be able to tolerate more than one drug. When 2 drugs are used, the most common combination is pemetrexed and either cisplatin or carboplatin. Other combinations might be used as well.
Pemetrexed lowers levels of folic acid and vitamin B12 in the body, so people getting pemetrexed need to get these vitamins as well to help avoid certain side effects.
Chemo drugs that might be used for HIPEC or PIPAC include:
- Cisplatin
- Carboplatin
- Mitomycin
- Doxorubicin
Sometimes a targeted therapy drug or an immunotherapy might be given as well.
Possible side effects of chemo
Chemo drugs attack cells in the body that are dividing quickly, which can lead to side effects. The side effects depend on the type and dose of drugs given, how they're given, and how long they're used. Intraperitoneal chemo tends to cause fewer problems than systemic chemo.
Common side effects include:
- Hair loss
- Mouth sores
- Loss of appetite
- Nausea and vomiting
- Diarrhea
- Increased chance of infections from having too few white blood cells
- Easy bruising or bleeding from having too few blood platelets
- Fatigue from having too few red blood cells
Some drugs can have other side effects. For example, cisplatin and carboplatin can cause peripheral neuropathy (nerve damage). This can sometimes lead to:
- Hearing loss
- Pain, burning, or tingling sensations in the hands and feet
- Sensitivity to cold or heat
- Weakness
These side effects usually go away after treatment is finished, but some can last a long time in some people. There are often ways to lessen these side effects. For example, drugs can be given to help prevent or reduce nausea and vomiting.
Be sure to ask your cancer care team about what to expect and to report any side effects or changes you notice so that you can get them treated right away. The doses of the drugs might need to be lowered or treatment might need to be delayed or stopped to keep the side effects from getting worse.
More information about chemotherapy
For more general information about how chemotherapy is used to treat cancer, see Chemotherapy.
To learn about some of the side effects listed here and how to manage them, see Managing Cancer-related Side Effects.
- Written by
- References
Developed by the American Cancer Society medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).
Alexander HR, Kindler HL, Nowak AK. Peritoneal mesothelioma: Treatment. UpToDate. 2025. Accessed at https://www.uptodate.com/contents/peritoneal-mesothelioma-treatment on November 24, 2025.
Janes SM, Alrifai D, Fennell DA. Perspectives on the treatment of malignant pleural mesothelioma. N Engl J Med. 2021;385(13):1207-1218.
Kaidar-Person O, Zagar T, Haithcock BE, Weiss J. Chapter 70: Diseases of the Pleura and Mediastinum. In: Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE, eds. Abeloff’s Clinical Oncology. 6th ed. Philadelphia, Pa: Elsevier; 2020.
Kindler HL, Ismaila N, Bazhenova L, et al. Treatment of Pleural Mesothelioma: ASCO Guideline Update. J Clin Oncol. 2025 Mar 10;43(8):1006-1038.
National Cancer Institute. Malignant Mesothelioma Treatment (PDQ®)–Patient Version. 2025. Accessed at https://www.cancer.gov/types/mesothelioma/patient/mesothelioma-treatment-pdq on November 24, 2025.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Mesothelioma: Peritoneal. Version 2.2026. Accessed at www.nccn.org on November 24, 2025.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Mesothelioma: Pleural. Version 2.2026. Accessed at www.nccn.org on November 24, 2025.
Pass HI, Tsao AS, Rosenzweig K. Initial management of malignant pleural mesothelioma. UpToDate. 2025. Accessed at https://www.uptodate.com/contents/initial-management-of-malignant-pleural-mesothelioma on November 24, 2025.
Tsao AS. Systemic treatment for unresectable malignant pleural mesothelioma. UpToDate. 2025. Accessed at https://www.uptodate.com/contents/systemic-treatment-for-unresectable-malignant-pleural-mesothelioma on November 24, 2025.
Last Revised: February 3, 2026
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
American Cancer Society Emails
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.


